Anteris Technologies Global Corp. (AVR) vs Embecta Corp. (EMBC)
- Anteris Technologies Global Corp. AVR 6.05 −4.87%
- Embecta Corp. EMBC 6.27 −2.79%
Anteris Technologies Global Corp. and Embecta Corp. are both Medical Instruments & Supplies companies. Anteris Technologies Global Corp. is the larger, with a market value of $619.8M against $365.5M — 1.7× the size. Anteris Technologies Global Corp. has negative trailing earnings, so its P/E is not meaningful; Embecta Corp. trades at 4.2×. Embecta Corp. grew revenue faster over the last twelve months: −7.60% against −9.56%. Embecta Corp. has the higher net margin (8.59% vs −4,619.3%) and the higher return on invested capital (21.4% vs 0.00%). Across the 16 metrics below, Embecta Corp. leads on 12 and Anteris Technologies Global Corp. on 4.
Valuation
Profitability
| Metric | AVR | EMBC | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 74.98% | 59.03% | 54.29% |
| Operating margin | (4,738.36%) | 21.94% | 1.07% |
| Net margin | (4,619.27%) | 8.59% | (1.61%) |
| Free cash flow margin | (3,937.07%) | 17.15% | 1.08% |
| Return on equity | (75.13%) | (13.65%) | (1.32%) |
| Return on assets | (66.31%) | 7.22% | 0.00% |
| Return on invested capital | 0.00% | 21.44% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack